Nimbus Therapeutics is headquartered in Cambridge, Massachusetts.
Nimbus Therapeutics is a life science company.
Nimbus Therapeutics was founded in 2009.
25 First Street Suite 404,
Cambridge, Massachusetts
02141
United States,
(617) 588-2655
www.nimbustx.com
Nimbus Therapeutics is a biotechnology company pioneering the application of computational chemistry to design treatments for substantial and underserved human diseases. The company’s focus on metabolic diseases, cancer and immune-inflammatory disorders reflects the mechanistic relationship between these disorders, and Nimbus’ ability to rapidly tackle well validated targets as well as those that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry, resulting in medicines with high potency, selectivity and other desirable drug-like properties.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.4/yr) | # | 1 | - | 2 | - | - | - | 3 |
| vol | $400M | $400M | ||||||
| 3 | ||||||||
| Financial | Deals |
|---|---|
|
J.P. Morgan Securities |
1 |
| Legal | Deals |
|---|---|
|
Goodwin Procter |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
